Aktie A40AZ1 NU-MED PLUS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Nu-Med Plus, Inc.

Aktien

A40AZ1

US67021R1041

NUMD

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:48:05 17.05.2024 		% 5 Tage % 1. Jan.
0,0483 USD +4,39 % Intraday Chart für Nu-Med Plus, Inc. +5,23 % +19,26 %
28.04. Nu-Med Plus, Inc. (OTCPK:NUMD) hat die Übernahme von Your Space, Inc. von William R. Colvin, Robert Papri, Arthur Hood, William Hayde und Dan Bittner abgeschlossen. CI
26.03. Nu-Med Plus, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Nu Med Plus : Material Agreement - Form 8-K
Nu-Med Plus, Inc. completed the acquisition of Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner.
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Nu-Med Plus, Inc. entered into a letter of intent to acquire Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner.
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
NU-MED PLUS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
NU-MED PLUS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND (form 10-K)
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Nu-Med Plus, Inc. Auditor Raises 'Going Concern' Doubt
Nu Med Plus : Change in Certifying Accountants - Form 8-K
NU-MED PLUS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
NU-MED PLUS, INC. Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K/A)
NU-MED PLUS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
NU-MED PLUS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Nu-Med Plus, Inc. announced that it has received $0.1 million in funding from Your Space, Inc
NU-MED PLUS, INC. : Change in Directors or Principal Officers (form 8-K)
Nu-Med Plus, Inc. Appoints Jeffrey L. Robins to the Board of Director
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A40AZ1 Aktie
  4. Nachrichten Nu-Med Plus, Inc.
  5. Andere Sprachen